As a result of the re-examination by the Food and Drug Safety Administration (Drug Management Team-No. 6412, effective date May 10, 2007), the precautions for use of Ramiril tablets (Ramipril) have been changed in accordance with the approval change order.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Lamiryl tablets
Attachments are original documents and may be in Korean. English editions are labeled separately.
Ramiril tablets 3.hwpRamiril tablets 3.hwp · 30 KBDownload ↓